CRISPR interference (CRISPRi) as transcriptional repression tool for Hungateiclostridium thermocellum DSM 1313

Summary Hungateiclostridium thermocellum DSM 1313 has biotechnological potential as a whole‐cell biocatalyst for ethanol production using lignocellulosic renewable sources. The full exploitation of H. thermocellum has been hampered due to the lack of simple and high‐throughput genome engineering too...

Full description

Bibliographic Details
Main Authors: Joyshree Ganguly, Maria Martin‐Pascual, Richard vanKranenburg
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Microbial Biotechnology
Online Access:https://doi.org/10.1111/1751-7915.13516
_version_ 1818042613533507584
author Joyshree Ganguly
Maria Martin‐Pascual
Richard vanKranenburg
author_facet Joyshree Ganguly
Maria Martin‐Pascual
Richard vanKranenburg
author_sort Joyshree Ganguly
collection DOAJ
description Summary Hungateiclostridium thermocellum DSM 1313 has biotechnological potential as a whole‐cell biocatalyst for ethanol production using lignocellulosic renewable sources. The full exploitation of H. thermocellum has been hampered due to the lack of simple and high‐throughput genome engineering tools. Recently in our research group, a thermophilic bacterial CRISPR–Cas9‐based system has been developed as a transcriptional suppression tool for regulation of gene expression. We applied ThermoCas9‐based CRISPR interference (CRISPRi) to repress the H. thermocellum central metabolic lactate dehydrogenase (ldh) and phosphotransacetylase (pta) genes. The effects of repression on target genes were studied based on transcriptional expression and product formation. Single‐guide RNA (sgRNA) under the control of native intergenic 16S/23S rRNA promoter from H. thermocellum directing the ThermodCas9 to the promoter region of both pta and ldh silencing transformants reduced expression up to 67% and 62% respectively. This resulted in 24% and 17% decrease in lactate and acetate production, correspondingly. Hence, the CRISPRi approach for H. thermocellum to downregulate metabolic genes can be used for remodelling of metabolic pathways without the requisite for genome engineering. These data established for the first time the feasibility of employing CRISPRi‐mediated gene repression of metabolic genes in H. thermocellum DSM 1313.
first_indexed 2024-12-10T08:49:06Z
format Article
id doaj.art-20cc5762cab740968b37411d413d5ebf
institution Directory Open Access Journal
issn 1751-7915
language English
last_indexed 2024-12-10T08:49:06Z
publishDate 2020-03-01
publisher Wiley
record_format Article
series Microbial Biotechnology
spelling doaj.art-20cc5762cab740968b37411d413d5ebf2022-12-22T01:55:38ZengWileyMicrobial Biotechnology1751-79152020-03-0113233934910.1111/1751-7915.13516CRISPR interference (CRISPRi) as transcriptional repression tool for Hungateiclostridium thermocellum DSM 1313Joyshree Ganguly0Maria Martin‐Pascual1Richard vanKranenburg2Corbion Arkelsedijk 46 4206 AC Gorinchem The NetherlandsLaboratory of Microbiology Wageningen University Stippeneng 4 6708 WE Wageningen The NetherlandsCorbion Arkelsedijk 46 4206 AC Gorinchem The NetherlandsSummary Hungateiclostridium thermocellum DSM 1313 has biotechnological potential as a whole‐cell biocatalyst for ethanol production using lignocellulosic renewable sources. The full exploitation of H. thermocellum has been hampered due to the lack of simple and high‐throughput genome engineering tools. Recently in our research group, a thermophilic bacterial CRISPR–Cas9‐based system has been developed as a transcriptional suppression tool for regulation of gene expression. We applied ThermoCas9‐based CRISPR interference (CRISPRi) to repress the H. thermocellum central metabolic lactate dehydrogenase (ldh) and phosphotransacetylase (pta) genes. The effects of repression on target genes were studied based on transcriptional expression and product formation. Single‐guide RNA (sgRNA) under the control of native intergenic 16S/23S rRNA promoter from H. thermocellum directing the ThermodCas9 to the promoter region of both pta and ldh silencing transformants reduced expression up to 67% and 62% respectively. This resulted in 24% and 17% decrease in lactate and acetate production, correspondingly. Hence, the CRISPRi approach for H. thermocellum to downregulate metabolic genes can be used for remodelling of metabolic pathways without the requisite for genome engineering. These data established for the first time the feasibility of employing CRISPRi‐mediated gene repression of metabolic genes in H. thermocellum DSM 1313.https://doi.org/10.1111/1751-7915.13516
spellingShingle Joyshree Ganguly
Maria Martin‐Pascual
Richard vanKranenburg
CRISPR interference (CRISPRi) as transcriptional repression tool for Hungateiclostridium thermocellum DSM 1313
Microbial Biotechnology
title CRISPR interference (CRISPRi) as transcriptional repression tool for Hungateiclostridium thermocellum DSM 1313
title_full CRISPR interference (CRISPRi) as transcriptional repression tool for Hungateiclostridium thermocellum DSM 1313
title_fullStr CRISPR interference (CRISPRi) as transcriptional repression tool for Hungateiclostridium thermocellum DSM 1313
title_full_unstemmed CRISPR interference (CRISPRi) as transcriptional repression tool for Hungateiclostridium thermocellum DSM 1313
title_short CRISPR interference (CRISPRi) as transcriptional repression tool for Hungateiclostridium thermocellum DSM 1313
title_sort crispr interference crispri as transcriptional repression tool for hungateiclostridium thermocellum dsm 1313
url https://doi.org/10.1111/1751-7915.13516
work_keys_str_mv AT joyshreeganguly crisprinterferencecrispriastranscriptionalrepressiontoolforhungateiclostridiumthermocellumdsm1313
AT mariamartinpascual crisprinterferencecrispriastranscriptionalrepressiontoolforhungateiclostridiumthermocellumdsm1313
AT richardvankranenburg crisprinterferencecrispriastranscriptionalrepressiontoolforhungateiclostridiumthermocellumdsm1313